Details of the Drug Reposition

General Information of This Drug (ID: DMJW3F4)

Drug Name
A168   DMJW3F4
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastroesophageal junction adenocarcinoma DISCVPML 2B71 Phase 1 [1]
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Klus Pharma